Glucosamine Sulfate Potassium Chloride PVP granule DC95
Basic Information
619
34
12
4.8(52)
Category
Subcategory & Sub-subcategory
Trade Type
Sell
Product Name
Glucosamine Sulfate Potassium Chloride PVP granule DC95
Specifications
- IUPAC Name: dipotassium;bis((2R,3R,4S,5R)-2-amino-3,4,5,6-tetrahydroxyhexanal);sulfuric acid;dichloride
- Purity Grade: Pharmaceutical Grade, purity ≥ 95%
- CAS Number: 1296149-08-0
- Chemical Formula: C12H28Cl2K2N2O14S
- Molecular Weight: 605.5
- Appearance: White, free-flowing granules
- Storage Conditions: Store in tight, light-resistant containers below 25°C
- Certificate of Analysis: Complies with USP 29
- Application: Excipient granule for direct-compression tablet manufacturing (PVP K-30 binder)
- Odour: Odourless
- Bulk Density: NLT 0.60g/ml
- As Tapped Density: Meet the requirement of USP29
- Particle Size: 100% through 10 mesh, 95% through 20 mesh
- Assay (HPLC): NLT 95%
- A: Infrared Absorption: Meets the requirement
- B: Tests for Chloride,Potassium,and Sulfate: Meets the requirement
- C: Retention time in the Assay: Corresponds to the reference standard
- Transm: >90.0% (10.0%Water Solut.-450nm)
- Specific Rotation〔α〕D20: +48.00°-- +52.00°
- PH (20mg/ml.aq.sol.): 3.0—5.0
- Loss on Drying: NMT 2.0%
- Residue on ignition: 25.3%--29.0%
- Chloride (Cl): 11.7%--12.3%
- Content of Sulfate: 14.7%--15.7%
- Potassium: 11.2%--12.3%
- Sodium: No Precipitate is Formed
- Heavy Metals: NMT 10 ppm
- Iron (fe): NMT 10 ppm
- Lead: NMT 0.5 ppm
- Arsenic (As): NMT 3.0 ppm
- Mercury: NMT 0.5 ppm
- Organic volatile impurities: Meets the Requirements
- Total Aerobic: NMT 1000 cfu/g
- Yeast & Mold: NMT 100 cfu/g
- E. Coli: Negative in 1g
- Salmonella: Negative in 1g
- Staphylococcus aureus: Negative in 10g
- Enterobacteria & other gram neg: NMT 100 cfu/g
- Packaging and Storage: Store in tight, light-resistant containers under 25 ℃
- Reason for Change: Updating Specification Format to USP 29
- Effective Date: Code & Version: DG2KCLG95/1
- Part Number: DG KCL 03
Other Information
Additional Description:
Jiangsu Aoxin Biotechnology, established in 1997, manufactures chiral intermediates and antibiotic active ingredients, distributing to markets across North America, Central/South America, Western and Eastern Europe, and Asia. The company competes on brand recognition, an experienced R&D staff, production capacity, and its willingness to accommodate buyers' specifications and small orders.
Ratings
(0)
(0)
(0)
(0)
(0)
Comments
Filters:
Sort by:
No comments available.
Matched Products & Services
B2B matches based on trade type, category, specifications & price range
Similar Products & Services
Products & Services related to what you're viewing
People Also Viewed
Other products & services viewed by people who looked at this product
Leave your rating & comment